期刊文献+

抗黏附多肽的聚乙二醇化研究 被引量:1

The pegylation of anti-adhesion polypeptide
原文传递
导出
摘要 目的观察聚乙二醇化抗黏附多肽酪-异亮-甘-丝-精(YIGSR)对人肝癌高转移细胞株MHCC97H体外基质黏附抑制能力和在大鼠血清体外的降解。方法将甲氧基聚乙二醇丙醛10000(mPEGALD10000)与YIGSR在PH4到6,摩尔比1:1到10:1条件下偶联成聚乙二醇化YIGSR(PEG—YIGSR)。比较两者的基质黏附抑制能力及在SD大鼠血清中的降解速率。结果修饰率可以达到99.9%以上,PEG-YIGSR的黏附抑制率达19.5%,且呈时间剂量依赖关系。PEG-YIGSR在大鼠血清中的降解速度明显慢于YIGSR,药时曲线下面积(AUC)分别为(1249±36)mg/min·L^-1和(1146±47)mg/min·L^-1。结论PEG—YIGSR保留了抗肿瘤细胞黏附的作用,且在体外血清中的降解速率减慢,有助于延长YIGSR发挥作用的时间。 Objective To investigate the modified methods of polyethylene glycol (PEG) to polypeptide YIGSR, and the degradation of PEG-YIGSR in serum of SD rats in vitro, and the adhesion inhibi- tory potential of PEG-YIGSR on the hepatoeellular carcinoma cell line MHCC97H cells. Methods YIGSR was reacted to the mPEGALD10000 synthesizing the pegylated YIGSR conjugate (PEG-YIGSR) under the certain conditions (pH 4 to 6 ,PEG: YIGSR 1:1 to 10:1 ). The couple rate of pegylation and the degradation speed of PEG-YIGSR in SD rat serum were detected by using the LC-MS method in vitro. The hepatocellular carcinoma cell line MHCC97H cells were treated with PEG-YIGSR, and then the cell adhesion potential was tested by in vitro cell-matrix adhesion test. Results The couple rate of pegylation was up to 99.9% in different pH values,and it was increased with the ineresse of PEG modifier dose. PEG-YIGSR markedly inhibited cell adhesion to laminin (LN) up to 19.5% in a dose-and time-dependent manner. The degradation speed of PEG-YIGSR in SD rat serum was slower than that of YIGSR in vitro [ AUC was (1249 +36) mg/min · L^-1 versus (1146 +47) mg/min· L^-1]. Conclusion PEG-YIGSR still kept original inhibition potential on MHCC97H cells adhesion to LN. The action time of PEG-YIGSR would extend due to its slow degradation in SD rat serum.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2009年第10期1301-1303,共3页 Chinese Journal of Experimental Surgery
基金 上海市卫生局科技发展基金资助项目 致谢:上海市徐汇区中心医院中心实验室的余琛、刘罡一在LC-MS检测中提供帮助,谨致谢忱.
关键词 肝细胞 黏附 聚乙二醇 多肽 Carcinoma, hepatocellular Adhesion Polyethylene glycol Polypeptide
  • 相关文献

参考文献11

  • 1Roberts M J, Bentley MD, Harris JM. Chemistry for peptide and protein PEGylation. Adv Drug Delivery Rev,2002,54:459476.
  • 2Harris JM, Chess RB. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov,2003,2:214-221.
  • 3Yamamoto Y, Tsutsumi Y, Mayumi T. Molecular design of bioconjugated cell adhesion peptide with a water-soluble polymeric modifier for enhancement of antimetastatic effect. Curr Drug Targets,2002,3 : 123- 130.
  • 4Grant DS, Kibbey MC, Kinsella JL, et al. The role of basement membrane in angiogenesis and tumor growth. Pathol Res Pract, 1994,190: 854-863.
  • 5王艳红,刘银坤,李文昌,叶胜龙,汤钊猷.抗黏附多肽对人肝癌高转移细胞系MHCC97侵袭转移的抑制作用[J].中华实验外科杂志,2004,21(10):1168-1169. 被引量:7
  • 6Mordenti J, Chen SA, Moore JA, et al. Interspecies scaling of clearance and volume of distribution data for five therapeutic proteins. Pham Res, 1991,8 : 1351-1359.
  • 7Veronese FM,Sacca B,Polverino de LP,et al. New PEGs for peptide and protein modification, suitable for identification of PEGylation site. Bioconju Chem,2001:62-70.
  • 8王艳红,李立新,孙瑞霞,陈洁,刘银坤,叶胜龙.ανβ3抗体对人肝癌细胞系MHCC97的黏附抑制作用[J].中华实验外科杂志,2006,23(5):634-634. 被引量:9
  • 9沈早卓,周俭,肖永胜,樊嘉,薛琼,高东梅,汤钊猷.聚乙二醇化干扰素-α联合卡培他滨对肝癌生长作用的影响[J].中华实验外科杂志,2006,23(3):274-275. 被引量:1
  • 10朱珺,王松梅,沈炜明,吴自荣,刘银坤.抗肿瘤转移多聚β肽聚乙二醇化的研究[J].中国新药与临床杂志,2005,24(9):723-726. 被引量:6

二级参考文献18

  • 1王艳红,刘银坤,李文昌,叶胜龙,汤钊猷.抗黏附多肽对人肝癌高转移细胞系MHCC97侵袭转移的抑制作用[J].中华实验外科杂志,2004,21(10):1168-1169. 被引量:7
  • 2王天浩,任正刚.整合素与肝癌转移的相关研究进展[J].中国临床医学,2004,11(6):1173-1175. 被引量:3
  • 3王松梅,朱珺,李岩,潘銮凤,查锡良,刘银坤.新型三聚β肽对人肝癌细胞系迁移和侵袭能力的影响[J].中华肝脏病杂志,2005,13(7):541-542. 被引量:2
  • 4Wu ZZ,Li P,Huang QP,et al.Inhibition of adhesion of hepatocellular carcinoma cells to basement membrane components by receptor competition with RGD-or YIGSR-containing synthetic peptides.Biorheology,2003,40:489-502.
  • 5Tsuchiya Y,Sawada S,Tsukada K,et al.A new pseudo-peptide of Arg-Gly-Asp (RGD) inhibits intrahepatic metastasis of orthotopically implanted murine hepatocellular carcinoma.Int J Oncol,2002,20:319-324.
  • 6UEMURA T, NEMOTO A, LIU YK. Synthetic peptide derived from a conserved sequence of integrin β subunit [ J ]. Res Adv in Biosci & Bioeng, 2000,23( 1 ) :65-83.
  • 7VERONESE FM, SACCA B, POLVERINO de LAURETO P, et al.New PEGs for peptide and protein modification, suitable for identification of PEGylation site [J]. Bioconju Chem, 2001 ( 1 ) :62-70.
  • 8Xiao YS,Tang ZY,Fan J,et al.Interferon-alpha 2a up-regulated thymidine phosphorylase and enhanced antitumor effect of capecitabine on hepatocellular carcinoma in nude mice.J Cancer Res Clin Oncol,2004,130:546-550.
  • 9Ishikawa T,Utoh M,Sawada N,et al.Tumor selective delivery of 5-Fluorouracil by capecitabine,a new oral fluoropyrimidine carbamate,in human cancer xenografts.Biochem Pharmacol,1998,55:1091-1097.
  • 10Wang L,Tang ZY,Qing LX,et al.High-dose and long-term therapy with interferon-alpha inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential.Hepatology,2000,32:43-48.

共引文献19

同被引文献11

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部